Lantheus Holdings, Inc. (NASDAQ:LNTH) – Analysts at Cantor Fitzgerald lifted their FY2017 earnings estimates for shares of Lantheus Holdings in a note issued to investors on Tuesday. Cantor Fitzgerald analyst T. Steed now anticipates that the medical equipment provider will post earnings per share of $0.99 for the year, up from their previous forecast of $0.94. Cantor Fitzgerald currently has a “Overweight” rating and a $22.00 target price on the stock. Cantor Fitzgerald also issued estimates for Lantheus Holdings’ FY2018 earnings at $1.02 EPS.
Lantheus Holdings (NASDAQ:LNTH) last released its quarterly earnings results on Tuesday, August 1st. The medical equipment provider reported $0.42 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.24 by $0.18. Lantheus Holdings had a negative return on equity of 37.47% and a net margin of 8.44%. The business had revenue of $88.83 million during the quarter, compared to analyst estimates of $80.56 million. During the same quarter in the previous year, the company posted $0.24 earnings per share. Lantheus Holdings’s revenue for the quarter was up 13.9% on a year-over-year basis. ILLEGAL ACTIVITY NOTICE: “Lantheus Holdings, Inc. (LNTH) to Post FY2017 Earnings of $0.99 Per Share, Cantor Fitzgerald Forecasts” was first posted by BNB Daily and is the sole property of of BNB Daily. If you are accessing this report on another website, it was stolen and reposted in violation of US & international copyright laws. The legal version of this report can be viewed at https://www.baseball-news-blog.com/2017/08/19/lantheus-holdings-inc-lnth-to-post-fy2017-earnings-of-0-99-per-share-cantor-fitzgerald-forecasts-updated.html.
LNTH has been the subject of several other research reports. Jefferies Group LLC restated a “buy” rating and issued a $22.00 price target (up previously from $18.00) on shares of Lantheus Holdings in a research note on Wednesday, August 2nd. Zacks Investment Research upgraded Lantheus Holdings from a “hold” rating to a “strong-buy” rating and set a $17.00 price objective on the stock in a report on Thursday, May 4th. Finally, Credit Suisse Group lifted their price objective on Lantheus Holdings from $14.00 to $19.00 and gave the stock a “neutral” rating in a report on Wednesday, August 2nd. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $18.60.
Shares of Lantheus Holdings (NASDAQ LNTH) opened at 18.90 on Wednesday. Lantheus Holdings has a 12-month low of $5.21 and a 12-month high of $20.45. The company has a market cap of $705.92 million, a price-to-earnings ratio of 25.82 and a beta of 0.91. The firm’s 50-day moving average price is $17.54 and its 200 day moving average price is $13.87.
In related news, Director David F. Burgstahler sold 3,000,000 shares of Lantheus Holdings stock in a transaction dated Tuesday, June 20th. The stock was sold at an average price of $14.87, for a total value of $44,610,000.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Michael P. Duffy sold 20,000 shares of Lantheus Holdings stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $15.42, for a total value of $308,400.00. Following the completion of the sale, the insider now owns 188,234 shares in the company, valued at $2,902,568.28. The disclosure for this sale can be found here. Over the last quarter, insiders sold 3,040,000 shares of company stock worth $45,252,800. 2.30% of the stock is currently owned by insiders.
A number of large investors have recently bought and sold shares of the company. State of Alaska Department of Revenue purchased a new stake in Lantheus Holdings during the second quarter valued at about $102,000. Municipal Employees Retirement System of Michigan purchased a new stake in Lantheus Holdings during the second quarter valued at about $107,000. LS Investment Advisors LLC purchased a new stake in Lantheus Holdings during the second quarter valued at about $112,000. BNP Paribas Arbitrage SA purchased a new stake in Lantheus Holdings during the second quarter valued at about $146,000. Finally, Koch Industries Inc. purchased a new stake in Lantheus Holdings during the first quarter valued at about $153,000. Institutional investors own 66.32% of the company’s stock.
About Lantheus Holdings
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.